CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hubei Biocause Pharmaceutical Co., Ltd. Company Snapshot
Hubei Biocause Pharmaceutical Co., Ltd. operates in the Life insurance sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hubei Biocause Pharmaceutical Co., Ltd. with three other insurance companies in Asia: Sbi Life Insurance Company Ltd of INDIA (2019 sales of 446.68 billion Indian Rupees [US$6.05 billion] of which 49% was Segment J - Linked Individual Life), Mercuries Life Insurance Co Ltd of TAIWAN (183.01 billion Taiwanese Dollars [US$6.43 billion] of which 43% was Personal Life Insurance Product), and Mercuries & Associates Holding Ltd which is also based in TAIWAN (209.68 billion Taiwanese Dollars [US$7.36 billion] of which 86% was Life Insurance).

Sales Analysis. Hubei Biocause Pharmaceutical Co., Ltd. reported sales of 50.19 billion Chinese Renmimbi (US$7.63 billion) for the year ending December of 2019. This represents an increase of 64.7% versus 2018, when the company's sales were 30.47 billion Chinese Renmimbi. Despite this increase, sales are still below the level achieved in 2017, when Hubei Biocause Pharmaceutical Co., Ltd. reported sales of 53.41 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hubei Biocause Pharmaceutical Co., Ltd.
  Stock Performance Chart for Hubei Biocause Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 5.06
(Figures in Chinese Renmimbi)
1 Week 1.0%   13 Weeks -4.2%  
4 Weeks -14.4%   52 Weeks -22.4%  
 
Hubei Biocause Pharmaceutical Co., Ltd. Key Data:
  Ticker: 000627 Country: China
  Exchanges: SZN Major Industry: Insurance
    Sub Industry: Life Insurance
  2019 Sales 50,192,912,467
(Year Ending Jan 2020).
Employees: 2,314
  Currency: Chinese Renmimbi Market Cap: 24,999,583,575
  Fiscal Yr Ends: December Shares Outstanding: 4,940,629,165
  Share Type: A Gu Closely Held Shares: 3,435,815,099
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.